AAAAAA
Results:
1-8
|
Results: 8
Authors:
Buss, N
Cammack, N
Citation: N. Buss et N. Cammack, Measuring the effectiveness of antiretroviral agents, ANTIVIR TH, 6(1), 2001, pp. 1-7
Authors:
Buss, N
Snell, P
Bock, J
Hsu, A
Jorga, K
Citation: N. Buss et al., Saquinavir and ritonavir pharmacokinetics following combined ritonavir andsaquinavir (soft gelatin capsules) administration, BR J CL PH, 52(3), 2001, pp. 255-264
Authors:
Muirhead, GJ
Wulff, MB
Fielding, A
Kleinermans, D
Buss, N
Citation: Gj. Muirhead et al., Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir, BR J CL PH, 50(2), 2000, pp. 99-107
Authors:
Buss, N
Citation: N. Buss, Effect of ritonavir on saquinavir metabolism, J AM MED A, 283(22), 2000, pp. 2936-2937
Authors:
Kilby, JM
Sfakianos, G
Gizzi, N
Siemon-Hryczyk, P
Ehrensing, E
Oo, C
Buss, N
Saag, MS
Citation: Jm. Kilby et al., Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults, ANTIM AG CH, 44(10), 2000, pp. 2672-2678
Authors:
Moyle, GJ
Sadler, M
Buss, N
Citation: Gj. Moyle et al., Plasma and cerebrospinal fluid saquinavir concentrations in patients receiving combination antiretroviral therapy, CLIN INF D, 28(2), 1999, pp. 403-404
Authors:
Buss, N
Duff, F
Citation: N. Buss et F. Duff, Protease inhibitors in HIV infection - Lipodystrophy may be a consequence of prolonged survival, BR MED J, 318(7176), 1999, pp. 122-122
Authors:
Gieschke, R
Fotteler, B
Buss, N
Steimer, JL
Citation: R. Gieschke et al., Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients, CLIN PHARMA, 37(1), 1999, pp. 75-86
Risultati:
1-8
|